0000899243-18-019325.txt : 20180703
0000899243-18-019325.hdr.sgml : 20180703
20180703184434
ACCESSION NUMBER: 0000899243-18-019325
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MRL Ventures Fund LLC
CENTRAL INDEX KEY: 0001742519
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38550
FILM NUMBER: 18938965
BUSINESS ADDRESS:
STREET 1: ONE MERCK DRIVE
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889
BUSINESS PHONE: 9087404000
MAIL ADDRESS:
STREET 1: ONE MERCK DRIVE
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Translate Bio, Inc.
CENTRAL INDEX KEY: 0001693415
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 611807780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-945-7361
MAIL ADDRESS:
STREET 1: 29 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: RaNA Therapeutics, Inc.
DATE OF NAME CHANGE: 20161228
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-02
1
0001693415
Translate Bio, Inc.
TBIO
0001742519
MRL Ventures Fund LLC
ONE MERCK DRIVE
WHITEHOUSE STATION
NJ
08889
0
0
1
0
Common Stock
2018-07-02
4
C
0
1848503
A
1848503
D
Common Stock
2018-07-02
4
P
0
25000
13.00
A
1873503
D
Series B Preferred Stock
2018-07-02
4
C
0
9259259
0.00
D
Common Stock
1666683
0
D
Series C Preferred Stock
2018-07-02
4
C
0
1010101
0.00
D
Common Stock
181819
0
D
The Series B and Series C Preferred Stock converted into Common Stock on a 5.5555-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.
/s/ Christine Brennan
2018-07-03